According to TipRanks.com, Hendrix is a 1-star analyst with an average return of -2.3% and a 36.0% success rate. Hendrix covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Brookdale Senior Living, and Bright Health Group.
HCA Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $267.38, a 10.7% upside from current levels. In a report released today, Cowen & Co. also maintained a Buy rating on the stock with a $241.00 price target.
The company has a one-year high of $279.02 and a one-year low of $196.22. Currently, HCA Healthcare has an average volume of 1.64M.
Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of HCA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Founded in 1968, HCA Healthcare, Inc. is a healthcare services company, based in Tennessee. The company operates general and psychiatric hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It also offers a full range of services to accommodate medical specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services.
Read More on HCA:
- Wedbush Reaffirms Their Buy Rating on McDonald’s (MCD)
- Robert W. Baird Thinks Rockwell Automation’s Stock is Going to Recover
- Robert W. Baird Thinks Zebra Tech’s Stock is Going to Recover
- Deutsche Bank Thinks Masco’s Stock is Going to Recover
- Deutsche Bank Reaffirms Their Buy Rating on Global Payments (GPN)